
{{Act of Congress
| congress       = 113
| session        = 1
| title          = To amend title IV of the Public Health Service Act to provide for a National Pediatric Research Network, including with respect to pediatric rare diseases or conditions.
| year           = 2013
| month          = 01
| day            = 14
| bill           = 225
| billtype       = hr
| purpose        = To amend title IV of the Public Health Service Act to provide for a National Pediatric Research Network, including with respect to pediatric rare diseases or conditions.
}}

{{Center|113th CONGRESS}}


{{Center|1st Session}}


{{Center|H. R. 225}}


{{Center|IN THE HOUSE OF REPRESENTATIVES}}


{{Center|January 14, 2013}}


{{Center|
[[Wikipedia:Lois Capps|Mrs. Capps]] (for
			 herself, 
[[Wikipedia:Cathy McMorris Rodgers|Mrs. McMorris Rodgers]],
			 
[[Wikipedia:Diana DeGette|Ms. DeGette]],
			 
[[Wikipedia:Gregg Harper|Mr. Harper]],
			 
[[Wikipedia:Doris Matsui|Ms. Matsui]], and
			 
[[Wikipedia:Peter T. King|Mr. King of New York]]) introduced the
			 following bill; which was referred to the [[Wikipedia:United States House Committee on Energy and Commerce|Committee on Energy and
			 Commerce]]}}


{{Center|A BILL}}

To amend title IV of the Public Health Service Act to
		  provide for a National Pediatric Research Network, including with respect to
		  pediatric rare diseases or conditions.

={{anchor|HAC2C2AF31A5A4757A721CBE21D963926}}Section 1. Short title=

This Act may be cited as the
			 “National Pediatric Research Network
			 Act of 2013”.

={{anchor|HF27F42EBDB8545D8880756EF4667C162}}Sec. 2. National
			 Pediatric Research Network=

Section 409D of the Public Health Service
			 Act (42 U.S.C. 284h; relating to the Pediatric Research Initiative) is
			 amended—
:(1) by redesignating
			 subsection (d) as subsection (f); and
:(2) by inserting after
			 subsection (c) the following:

<blockquote>

==={{anchor|H64AE1DD19A474B1FA708DBC9421C5EFC}}(d) National
				Pediatric Research Network– ===



===={{anchor|H232E66415814467E9654E34ACA1F4E91}}(1) Network– ====

In
				carrying out the Initiative, the [[Wikipedia:National Institutes of Health|Director of NIH]], acting through the [[Wikipedia:National Institutes of Health|Director
				of the Eunice Kennedy Shriver National Institute of Child Health and Human
				Development]] and in collaboration with other appropriate national research
				institutes and national centers that carry out activities involving pediatric
				research, may provide for the establishment of a National Pediatric Research
				Network consisting of the pediatric research consortia receiving awards under
				paragraph (2).

===={{anchor|H4FA86B31C09F4F0896795FBE60609BFC}}(2) Pediatric
				research consortia– ====



====={{anchor|HCAC325CD23E24E088DDE9649BD67F328}}(A) In
				general– =====

The [[Wikipedia:National Institutes of Health|Director of the
				Institute]] may award funding, including through grants, contracts, or other
				mechanisms, to public or private nonprofit entities—
:(i) for planning,
				establishing, or strengthening pediatric research consortia; and
:(ii) for providing basic operating support for
				such consortia, including with respect to—
::(I) basic, clinical, behavioral, or
				translational research to meet unmet needs for pediatric research; and
::(II) training researchers in pediatric research
				techniques in order to address unmet pediatric research needs.

====={{anchor|H647EF1407D7D4651B047210D36C605AC}}(B) Research– =====

The
				[[Wikipedia:National Institutes of Health|Director of NIH]] shall ensure that—
:(i) each consortium receiving an award under
				subparagraph (A) conducts or supports at least one category of research
				described in subparagraph (A)(ii)(I) and collectively such consortia conduct or
				support all such categories of research; and
:(ii) one or more such consortia provide training
				described in subparagraph (A)(ii)(II).

====={{anchor|H465DCA1A8C3147BB9782C36FD5D5C756}}(C) Number of
				consortia– =====

The [[Wikipedia:National Institutes of Health|Director of NIH]] may make awards under this
				paragraph for not more than 20 pediatric research consortia.

====={{anchor|H31911DC8DA234B7D9F34E42A16767A3B}}(D) Organization of
				consortium– =====

Each consortium receiving an award under subparagraph
				(A) shall—
:(i) be
				formed from a collaboration of cooperating institutions;
:(ii) be coordinated by
				a lead institution;
:(iii) agree to disseminate scientific findings,
				including from clinical trials, rapidly and efficiently; and
:(iv) meet such
				requirements as may be prescribed by the [[Wikipedia:National Institutes of Health|Director of NIH]].

====={{anchor|H12B337DA7419498BA3194130C8B18123}}(E) Supplement, not
				supplant– =====

Any support received
				by a consortium under subparagraph (A) shall be used to supplement, and not
				supplant, other public or private support for activities authorized to be
				supported under this paragraph.

====={{anchor|HF01C9A23691841AEA1DB2CA5AE38A319}}(F) Duration of
				support– =====

Support of a
				consortium under subparagraph (A) may be for a period of not to exceed 5 years.
				Such period may be extended at the discretion of the [[Wikipedia:National Institutes of Health|Director of NIH]].

===={{anchor|H5B8B2E320B3E4345B62298CE200B9B3A}}(3) Coordination of
				consortia activities– ====

The [[Wikipedia:National Institutes of Health|Director of NIH]] shall—
:(A) as appropriate,
				provide for the coordination of activities (including the exchange of
				information and regular communication) among the consortia established pursuant
				to paragraph (2); and
:(B) require the
				periodic preparation and submission to the [[Wikipedia:National Institutes of Health|Director]] of reports on the
				activities of each such consortium.

===={{anchor|H1B06C9F91E344EAEAE31F50D0F0C621D}}(4) Assistance with
				registries– ====

Each consortium
				receiving an award under paragraph (2)(A) shall provide assistance to the
				[[Wikipedia:Centers for Disease Control and Prevention|Centers for Disease Control and Prevention]] in the establishment or expansion of
				patient registries and other surveillance systems as appropriate and upon
				request by the [[Wikipedia:Centers for Disease Control and Prevention|Director of the Centers]].

==={{anchor|H736B489910B94FA4A116B6498A50B243}}(e) Research on
				pediatric rare diseases or conditions– ===



===={{anchor|H68F36BEABC62452F9CB4D27E76C8227D}}(1) In
				general– ====

In making awards
				under subsection (d)(2) for pediatric research consortia, the [[Wikipedia:National Institutes of Health|Director of NIH]]
				shall ensure that an appropriate number of such awards are awarded to such
				consortia that agree to—
:(A) focus primarily on
				pediatric rare diseases or conditions (including any such diseases or
				conditions that are genetic disorders (such as spinal muscular atrophy and
				Duchenne muscular dystrophy) or are related to birth defects (such as Down
				syndrome and fragile X)); and
:(B) conduct or coordinate one or more multisite
				clinical trials of therapies for, or approaches to, the prevention, diagnosis,
				or treatment of one or more pediatric rare diseases or conditions.

===={{anchor|H6BC6115C75C049C89E20757AC04037AC}}(2) Data
				coordinating center– ====



====={{anchor|H4E8F354573DE4B9BB530B56F18D050F9}}(A) Establishment– =====

In
				connection with support of consortia described in paragraph (1), the [[Wikipedia:National Institutes of Health|Director
				of NIH]] shall establish a data coordinating center for the following
				purposes:
:(i) To
				distribute the scientific findings referred to in paragraph (1)(C).
:(ii) To provide
				assistance in the design and conduct of collaborative research projects and the
				management, analysis, and storage of data associated with such projects.
:(iii) To organize and
				conduct multisite monitoring activities.

====={{anchor|H3FECC2FD58F14CDDB77F888F365AB8C3}}(B) Reporting– =====

The [[Wikipedia:National Institutes of Health|Director of NIH]] shall—
:(i) require the data
				coordinating center established under subparagraph (A) to provide regular
				reports to the [[Wikipedia:National Institutes of Health|Director of NIH]] and the [[Wikipedia:Food and Drug Administration|Commissioner of Food and Drugs]] on
				research conducted by consortia described in paragraph (1), including
				information on enrollment in clinical trials and the allocation of resources
				with respect to such research; and
:(ii) as appropriate,
				incorporate information reported under clause (i) into the [[Wikipedia:National Institutes of Health|Director’s]] biennial
				reports under section
				403..
</blockquote>
